Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumor-scanning agents compared in an animal model.

T Konikowski, M F JPAHNS, P Haynie

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |March 1, 1975
    PubMed
    Summary

    Researchers compared sixteen radiopharmaceuticals for brain tumor imaging in mice. Results show 111-indium chloride at pH 1.5 offers the best biological characteristics for brain tumor detection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.

    The Journal of urology·1987
    Same author

    Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1987
    Same author

    Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.

    NCI monographs : a publication of the National Cancer Institute·1987
    Same author

    Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.

    Cancer research·1985
    Same author

    Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.

    Cancer research·1985
    Same author

    Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.

    Cancer research·1985

    Area of Science:

    • Nuclear medicine
    • Oncology
    • Medical imaging

    Background:

    • Accurate brain tumor localization is crucial for effective treatment planning.
    • Developing novel radiopharmaceuticals with improved targeting and imaging properties is an ongoing area of research.
    • Comparative studies are essential to identify the most effective agents for clinical use.

    Purpose of the Study:

    • To evaluate and compare the efficacy of sixteen different radiopharmaceuticals for brain tumor imaging.
    • To establish a rating system for the intercomparison of radiopharmaceuticals in a preclinical model.
    • To identify the radiopharmaceutical with the most favorable biological characteristics for brain tumor imaging.

    Main Methods:

    • A preclinical mouse model of brain tumors was utilized for the study.
    • Sixteen radiopharmaceuticals were administered and their uptake in tumor tissue was assessed.
    • A standardized rating system was developed and applied for quantitative comparison.
    • Biological characteristics such as tumor-to-normal tissue ratios and biodistribution were evaluated.

    Main Results:

    • Significant variations in uptake and targeting were observed among the sixteen evaluated radiopharmaceuticals.
    • The developed rating system provided a quantitative basis for comparing the agents.
    • 111-indium chloride, when injected at a specific pH (1.5), demonstrated superior performance.
    • 111-indium chloride exhibited the most favorable biological characteristics for brain tumor imaging compared to other agents.

    Conclusions:

    • 111-indium chloride at pH 1.5 emerges as a promising radiopharmaceutical for brain tumor imaging.
    • The established rating system can be valuable for future preclinical evaluations of neuroimaging agents.
    • Further clinical validation is warranted to confirm the efficacy of 111-indium chloride in human patients.

    Related Experiment Videos